AI assistant
Sending…
WD 40 CO — Director's Dealing 2011
Jul 12, 2011
31407_dirs_2011-07-12_7cc49dc4-cc7c-4628-bde6-fe5e4b74058f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WD 40 CO (WDFC)
CIK: 0000105132
Period of Report: 2011-07-08
Reporting Person: NOBLE WILLIAM B (Managing Director, Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-07-08 | Common Stock | M | 47 | $27.67 | Acquired | 17452 | Direct |
| 2011-07-08 | Common Stock | M | 47 | $43.91 | Disposed | 17405 | Direct |
| 2011-07-08 | Common Stock | M | 5000 | $29.30 | Acquired | 22405 | Direct |
| 2011-07-08 | Common Stock | S | 5000 | $44.30 | Disposed | 17405 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-08 | Non-qualified Stock Option | $27.67 | M | 47 | Disposed | 2014-10-19 | Common Stock (47) | Direct |
| 2011-07-08 | Non-qualified Stock Option | $29.30 | M | 5000 | Disposed | 2013-09-24 | Common Stock (5000) | Direct |
Footnotes
F1: Transaction pusuant to trading plan adopted pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.
F2: Total includes 8,359 Restricted Stock Units, 4,388 of which are subject to future vesting, and 4,800 Performance Share Units, all of which are subject to future vesting.
F3: Not applicable.
F4: In addition to the reported options, the reporting person holds options to acquire 30,000 common shares as follows: 10,000 NQSO exercisable 10/17/09 at $35.99 exp. 10/17/16; and 20,000 NQSO 10/16/10 at $36.03 exp. 10/16/17.
More from WD 40 CO
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 9
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 6
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2026
Jan 8